Pakistan shuts drug counterfeiting operation; drug regulators commanding higher pay;

> A study has found that pay for drug regulators throughout the world has increased along with the expectation that they understand the entire product cycle of medications. Story

> Authorities in Pakistan have closed a drugmaker they say was manufacturing counterfeit drugs, arresting its owner and his son. Story

> The FDA has again issued an updated warning about the Mexican over-the-counter pain drug, Reumofan Plus and Reumofan Plus Premium, which it says contain undeclared prescription APIs and have been tied to severe illnesses and even deaths. Release 

> Danish regulators tested glycerol excipients from drugmakers there as an extension of its 2-year-old program to test APIs there. Story 

And Finally... After a yearlong pilot, Ahmedabad, India-based WestCoast Pharmaceuticals has launched, an online pharmacy store to reach what it says are 17.5 million active Internet users. Story

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.